{"id":43436,"date":"2026-02-14T16:01:09","date_gmt":"2026-02-14T16:01:09","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/enzyme-replacement-therapy-mordor\/"},"modified":"2026-03-27T09:22:44","modified_gmt":"2026-03-27T00:22:44","slug":"enzyme-replacement-therapy-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/enzyme-replacement-therapy-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ud6a8\uc18c \ub300\uccb4 \uc694\ubc95 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/enzyme-replacement-therapy-1750345040349-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/enzyme-replacement-therapy-size-image-1770817677356.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \ud76c\uadc0 \uc9c8\ud658 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc815\ubd80 \uc778\uc13c\ud2f0\ube0c \ubc0f \uc790\uae08 \uc9c0\uc6d0<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud504\ub85c\uadf8\ub7a8 \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.4 \ud658\uc790 \uc911\uc2ec \uce58\ub8cc\ub85c\uc758 \uc804\ud658<\/li>\n<li class=\"toc-level-3\">4.2.5 \ud6a8\uc18c \uacf5\ud559\uc758 \uae30\uc220 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.6 \ud601\uc2e0\uc801\uc778 \uc0c1\ud658 \ubaa8\ub378<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uce58\ub8cc \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uba74\uc5ed\uc6d0\uc131 \ubb38\uc81c<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc2e0\ud765 \uce58\ub8cc\ubc95\uacfc\uc758 \uacbd\uc7c1<\/li>\n<li class=\"toc-level-3\">4.3.4 \uacf5\uae09\ub9dd \ubb38\uc81c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \ud6a8\uc18c \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc774\ubbf8\uae00\ub8e8\uc138\ub77c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc544\uac08\uc2dc\ub2e4\uc81c \uc54c\ud30c<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc544\uac08\uc2dc\ub2e4\uc81c \ubca0\ud0c0<\/li>\n<li class=\"toc-level-3\">5.1.4 \ubca8\ub77c\uae00\ub8e8\uc138\ub77c\uc81c \uc54c\ud30c<\/li>\n<li class=\"toc-level-3\">5.1.5 \ud0c8\ub9ac\uae00\ub8e8\uc138\ub77c\uc81c \uc54c\ud30c<\/li>\n<li class=\"toc-level-3\">5.1.6 \uc54c\uae00\ub8e8\ucf54\uc2dc\ub2e4\uc81c \uc54c\ud30c<\/li>\n<li class=\"toc-level-3\">5.1.7 \uc544\ubc1c\uae00\ub8e8\ucf54\uc2dc\ub2e4\uc81c \uc54c\ud30c<\/li>\n<li class=\"toc-level-3\">5.1.8 \uac08\uc124\ud30c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.9 \uc774\ub450\uc124\ud30c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.10 \uae30\ud0c0 \ud6a8\uc18c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uace0\uc154\ubcd1 (\uc81c1\ud615, \uc81c2\ud615, \uc81c3\ud615)<\/li>\n<li class=\"toc-level-3\">5.2.2 \ud3fc\ud398\ubcd1 (\uc601\uc544\ud615 &amp; \uc9c0\ubc1c\ud615)<\/li>\n<li class=\"toc-level-3\">5.2.3 \ud30c\ube0c\ub9ac\ubcd1<\/li>\n<li class=\"toc-level-3\">5.2.4 MPS I (\ud5d0\ub7ec \uc99d\ud6c4\uad70)<\/li>\n<li class=\"toc-level-3\">5.2.5 MPS II (\ud5cc\ud130 \uc99d\ud6c4\uad70)<\/li>\n<li class=\"toc-level-3\">5.2.6 MPS IV (\ubaa8\ub974\ud0a4\uc624 \uc99d\ud6c4\uad70)<\/li>\n<li class=\"toc-level-3\">5.2.7 \uae30\ud0c0 \uc801\uc6a9 \ubd84\uc57c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc815\ub9e5 \uc8fc\uc785<\/li>\n<li class=\"toc-level-3\">5.3.2 \ud53c\ud558<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc81c\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ud45c\uc900 \uc7ac\uc870\ud569 \ud6a8\uc18c<\/li>\n<li class=\"toc-level-3\">5.4.2 PEG\ud654 \/ \uc735\ud569 \ub2e8\ubc31\uc9c8<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc720\uc804\uc790 \ud65c\uc131\ud654 \ucc28\uc138\ub300 \ud6a8\uc18c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubcd1\uc6d0 &amp; \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<li class=\"toc-level-3\">5.5.2 \uac00\uc815 \uc758\ub8cc \ud658\uacbd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc8fc\uc785 \uc13c\ud130<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \uc0ac\uc5c5 \ubd80\ubb38, \uc7ac\ubb34, \uc9c1\uc6d0 \uc218, \uc8fc\uc694 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704, \uc2dc\uc7a5 \uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uc2e0 \uac1c\ubc1c \ubd84\uc11d \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Sanofi (Genzyme)<\/li>\n<li class=\"toc-level-3\">6.3.2 Takeda Pharmaceutical Co. Ltd<\/li>\n<li class=\"toc-level-3\">6.3.3 BioMarin Pharmaceutical Inc.<\/li>\n<li class=\"toc-level-3\">6.3.4 Amicus Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.5 Ultragenyx Pharmaceutical Inc.<\/li>\n<li class=\"toc-level-3\">6.3.6 Spark Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.7 JCR Pharmaceuticals Co. Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.8 Protalix Biotherapeutics<\/li>\n<li class=\"toc-level-3\">6.3.9 Chiesi Farmaceutici S.p.A.<\/li>\n<li class=\"toc-level-3\">6.3.10 GC Pharma (Green Cross Corp.)<\/li>\n<li class=\"toc-level-3\">6.3.11 ISU Abxis<\/li>\n<li class=\"toc-level-3\">6.3.12 Denali Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.13 CANbridge Pharmaceuticals Inc.<\/li>\n<li class=\"toc-level-3\">6.3.14 Pharming Group N.V.<\/li>\n<li class=\"toc-level-3\">6.3.15 SOBI (Orphan Biovitrum)<\/li>\n<li class=\"toc-level-3\">6.3.16 Avacta Group plc<\/li>\n<li class=\"toc-level-3\">6.3.17 Orchard Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.18 EUSA Pharma<\/li>\n<li class=\"toc-level-3\">6.3.19 Idorsia Pharmaceuticals<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud6a8\uc18c \ub300\uccb4 \uc694\ubc95(Enzyme Replacement Therapy, ERT) \uc2dc\uc7a5 \uac1c\uc694 \ubcf4\uace0\uc11c \uc694\uc57d (2026-2031)<\/p>\n<p>Mordor Intelligence\uc758 \ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \ud6a8\uc18c \ub300\uccb4 \uc694\ubc95(Enzyme Replacement Therapy, ERT) \uc2dc\uc7a5\uc740 2025\ub144 160.1\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 174.5\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud588\uc73c\uba70, 2031\ub144\uc5d0\ub294 268.3\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 8.99%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c, \ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc73c\ub85c \ud3c9\uac00\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ubd84\uc11d \uc694\uc57d<\/p>\n<p>ERT \uc2dc\uc7a5\uc758 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc740 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac\uc758 \ud655\ub300, \uc9c4\ub2e8 \ub3c4\uad6c\uc758 \ubc1c\uc804, \ub9ac\uc18c\uc880 \ucd95\uc801 \uc9c8\ud658(Lysosomal Storage Disorders, LSD)\uc5d0 \ub300\ud55c \uc778\uc2dd \uc99d\uac00\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc694\uc778\ub4e4\uc740 \ud604\uc7ac \ub9ce\uc740 \uc758\ub8cc \uc2dc\uc2a4\ud15c\uc5d0\uc11c \uc784\uc0c1\uc801 \uc6b0\uc120\uc21c\uc704\ub97c \ud615\uc131\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uae30\uc220 \uae30\ubc18\uc758 \ud6a8\uc18c \uacf5\ud559 \ubc1c\uc804\uacfc \uc7ac\ud0dd \uc8fc\uc785\uc73c\ub85c\uc758 \uc804\ud658\uc740 \uce58\ub8cc \uacbd\ub85c\ub97c \uc7ac\ud3b8\ud558\uace0 \ubcd1\uc6d0 \ud63c\uc7a1\uc744 \uc644\ud654\ud558\uba70 \ud658\uc790 \uc21c\uc751\ub3c4\ub97c \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uaddc\uc81c \uae30\uad00\uc740 \ud76c\uadc0 \uc9c8\ud658 \uce58\ub8cc\uc81c \uc2b9\uc778\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc73c\uba70, \uac00\uce58 \uae30\ubc18 \uacc4\uc57d\uc740 \uc0c8\ub85c\uc6b4 \uac00\uaca9 \ucc45\uc815 \ubc29\uc2dd\uc744 \uc2dc\ud5d8\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uae00\ub85c\ubc8c \ucdcc\uc7a5 \ud6a8\uc18c \ubd80\uc871 \uc0ac\ud0dc\uac00 6\ub9cc \uba85 \uc774\uc0c1\uc758 \uc601\uad6d \ud658\uc790\ub4e4\uc5d0\uac8c \ucde8\uc57d\uc131\uc744 \ub178\ucd9c\uc2dc\ud0a8 \ud6c4, \uacf5\uae09 \ud0c4\ub825\uc131\uc740 \uc804\ub7b5\uc801 \ud544\uc218 \uc694\uc18c\uac00 \ub418\uc5c8\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc810<\/p>\n<p>*   \ud6a8\uc18c \uc720\ud615\ubcc4: \uc774\ubbf8\uae00\ub8e8\uc138\ub77c\uc81c(Imiglucerase)\uac00 2025\ub144 ERT \uc2dc\uc7a5 \uc810\uc720\uc728 38.05%\ub85c \uc120\ub450\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uc544\ubc1c\uae00\ub8e8\ucf54\uc2dc\ub2e4\uc81c \uc54c\ud30c(Avalglucosidase alfa)\ub294 2031\ub144\uae4c\uc9c0 11.12%\uc758 CAGR\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc801\uc6a9 \ubd84\uc57c\ubcc4: \uace0\uc154\ubcd1(Gaucher disease)\uc774 2025\ub144 ERT \uc2dc\uc7a5 \uaddc\ubaa8\uc758 42.87%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \ud3fc\ud398\ubcd1(Pompe disease)\uc740 2031\ub144\uae4c\uc9c0 11.02%\uc758 CAGR\ub85c \ud655\ub300\ub420 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c\ubcc4: \uc815\ub9e5 \uc8fc\uc785(Intravenous infusions)\uc774 2025\ub144 \ub9e4\ucd9c\uc758 91.75%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \ud53c\ud558 \uc8fc\uc0ac(Subcutaneous delivery)\ub294 10.12%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc81c\ud615\ubcc4: \ud45c\uc900 \uc7ac\uc870\ud569 \ud6a8\uc18c(Standard recombinant enzymes)\uac00 2025\ub144 ERT \uc2dc\uc7a5 \uc810\uc720\uc728 54.60%\ub97c \uae30\ub85d\ud588\uc73c\uba70, PEG\ud654(PEGylated) \uc81c\ud615\uc740 9.85%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ubcd1\uc6d0 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9\uc774 2025\ub144 \uc810\uc720\uc728 71.90%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uc7ac\ud0dd \uc758\ub8cc(Home healthcare)\ub294 12.10%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ucc44\ub110\uc785\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8\uac00 2025\ub144 38.10%\uc758 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 10.08%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae00\ub85c\ubc8c \ud6a8\uc18c \ub300\uccb4 \uc694\ubc95 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<\/p>\n<p>\uc131\uc7a5 \ub3d9\ub825:<\/p>\n<p>*   \ud76c\uadc0 \uc9c8\ud658 \uc720\ubcd1\ub960 \uc99d\uac00 (+2.1% CAGR \uc601\ud5a5): \uc911\uad6d\uc758 \uc2e0\uc0dd\uc544 \uc720\uc804\uccb4 \ud504\ub85c\uadf8\ub7a8\uc5d0\uc11c 1,512\uba85\ub2f9 1\uba85\uaf34\ub85c \ub9ac\uc18c\uc880 \ucd95\uc801 \uc9c8\ud658\uc774 \ud655\uc778\ub418\uba74\uc11c, \uc9c4\ub2e8\ub418\uc9c0 \uc54a\uc740 \ud658\uc790\uad70\uc774 \uc0c1\ub2f9\ud558\ub2e4\ub294 \uac83\uc774 \ub4dc\ub7ec\ub0ac\uace0, \uc774\ub294 ERT \uc2dc\uc7a5\uc758 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc870\uae30 \uc9c4\ub2e8\uc740 \ub3cc\uc774\ud0ac \uc218 \uc5c6\ub294 \uc7a5\uae30 \uc190\uc0c1 \uc774\uc804\uc5d0 \uac1c\uc785\ud560 \uc218 \uc788\uac8c \ud558\uc5ec, \ud6c4\uae30 \ub2e8\uacc4 \uc99d\uc0c1 \uad00\ub9ac\uc5d0 \ube44\ud574 \ud3c9\uc0dd \ube44\uc6a9\uc744 \uc808\uac10\ud569\ub2c8\ub2e4. \ubcf4\ud5d8\uc0ac\ub4e4\uc740 \uc870\uae30 \uce58\ub8cc\ub97c \uc608\ubc29\uc801 \uc9c0\ucd9c\ub85c \uac04\uc8fc\ud558\ub294 \uacbd\ud5a5\uc774 \ucee4\uc9c0\uace0 \uc788\uc73c\uba70, \uc774\ub294 \ud76c\uadc0 \uc9c8\ud658 \uc608\uc0b0\uc758 \uc7ac\uc870\uc815\uc744 \uac00\uc838\uc635\ub2c8\ub2e4.<br \/>\n*   \uc815\ubd80 \uc778\uc13c\ud2f0\ube0c \ubc0f \uc790\uae08 \uc9c0\uc6d0 (+1.8% CAGR \uc601\ud5a5): 2024\ub144 \ubbf8\uad6d FDA\uac00 M6P Therapeutics\uc5d0 6\uac1c\uc758 \ud76c\uadc0 \uc18c\uc544 \uc9c8\ud658 \uc9c0\uc815\uc744 \ubd80\uc5ec\ud55c \uac83\uc740 \ud6a8\uc18c \ud6c4\ubcf4 \ubb3c\uc9c8\uc758 \uac1c\ubc1c \uae30\uac04\uc744 \ub2e8\ucd95\uc2dc\ud0a4\ub294 \uaddc\uc81c \uacbd\ub85c\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc720\ub7fd\uc758 \ud76c\uadc0 \uc720\uc804\uccb4 \uce58\ub8cc \uae30\uae08(Orphan Genomic Therapies Fund) \uc81c\uc548\uc740 \ud601\uc2e0\uacfc \uacf5\ud3c9\ud55c \uc811\uadfc\uc131\uc744 \ubaa8\ub450 \uc9c0\uc6d0\ud558\uace0\uc790 \ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc815\ucc45\ub4e4\uc740 \ubc14\uc774\uc624 \uc81c\uc57d \uae30\uc5c5\uc758 \uc790\ubcf8 \uc704\ud5d8\uc744 \uc904\uc774\uace0 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc\ub97c \uac00\uc18d\ud654\ud558\uc5ec ERT \uc2dc\uc7a5 \ub0b4 \uacbd\uc7c1 \uac15\ub3c4\ub97c \ub192\uc785\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uc0dd\uc544 \uc120\ubcc4 \ud504\ub85c\uadf8\ub7a8 \ud655\ub300 (+1.5% CAGR \uc601\ud5a5): UCSF\uc758 PEARL \uc784\uc0c1 \uc2dc\ud5d8\uc740 \ubba4\ucf54\ub2e4\ub2f9\uc99d 6\ud615(mucopolysaccharidosis type VI) \ubc0f \uc601\uc544 \ubc1c\ubcd1 \ud3fc\ud398\ubcd1\uc5d0 \ub300\ud55c \uc0b0\uc804 \ud6a8\uc18c \uce58\ub8cc\ub97c \uc2dc\ud589\ud558\uc5ec, \uc0b0\ud6c4 \ud56d\uccb4 \ud615\uc131\uc744 \uc7a0\uc7ac\uc801\uc73c\ub85c \uc81c\uac70\ud560 \uc218 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ud3ec\uad04\uc801\uc778 \ud328\ub110\uc744 \ucd94\uac00\ud558\ub294 \uad6d\uac00\ub4e4\uc740 \uc9c8\ubcd1\uc744 \uc218\uac1c\uc6d4 \ub610\ub294 \uc218\ub144 \ub354 \uc77c\ucc0d \ubc1c\uacac\ud558\uc5ec, \uc5ed\uc0ac\uc801\uc73c\ub85c \ud3c9\uc0dd \uc7a5\uc560\ub97c \uc720\ubc1c\ud588\ub358 \uc2e0\uacbd\ud559\uc801 \ubc0f \uace8\uaca9 \uc190\uc0c1\uc744 \uc608\ubc29\ud560 \uc218 \uc788\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \ud658\uc790 \uc911\uc2ec \uce58\ub8cc\ub85c\uc758 \uc804\ud658 (+1.2% CAGR \uc601\ud5a5): \uc774\ud0c8\ub9ac\uc544 \ucf54\ud638\ud2b8 \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74 \ud6a8\uc18c \uc8fc\uc785\uc744 \ubcd1\uc6d0\uc5d0\uc11c \uc9d1\uc73c\ub85c \uc62e\uae38 \uacbd\uc6b0 \uc9c1\uc811 \ube44\uc6a9\uc774 25-50% \uc808\uac10\ub418\uba70, \uc21c\uc751\ub3c4\uac00 \ub192\uc544\uc9c0\uace0 \ud658\uc790 \uc2a4\ud2b8\ub808\uc2a4\uac00 \ud604\uc800\ud788 \uac10\uc18c\ud569\ub2c8\ub2e4. COVID-19 \ud32c\ub370\ubbf9 \ub3d9\uc548 \uc6d0\uaca9 \ubaa8\ub2c8\ud130\ub9c1 \uae30\uc220\uacfc \uac04\ud638\uc0ac \uc8fc\ub3c4 \uc544\uc6c3\ub9ac\uce58\ub294 \uc7ac\ud0dd \ud22c\uc5ec\uc758 \uc548\uc804\uc131\uc744 \uc785\uc99d\ud558\uc5ec, \ud658\uc790 \uc911\uc2ec \ubaa8\ub378\uc774 ERT \uc2dc\uc7a5\uc758 \uc601\uad6c\uc801\uc778 \ud2b9\uc9d5\uc73c\ub85c \uc790\ub9ac \uc7a1\uac8c \ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud6a8\uc18c \uacf5\ud559 \uae30\uc220 \ubc1c\uc804 (+1.7% CAGR \uc601\ud5a5): \ud6a8\uc18c \uacf5\ud559\uc758 \uae30\uc220 \ubc1c\uc804\uc740 \ub354 \uae34 \ubc18\uac10\uae30, \ub0ae\uc740 \uba74\uc5ed\uc6d0\uc131, \uac10\uc18c\ub41c \uc8fc\uc785 \ube48\ub3c4\ub97c \uac00\ub2a5\ud558\uac8c \ud558\uc5ec ERT\uc758 \ud6a8\uc728\uc131\uacfc \ud658\uc790 \ud3b8\uc758\uc131\uc744 \ud5a5\uc0c1\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \ud601\uc2e0\uc801\uc778 \uc0c1\ud658 \ubaa8\ub378 (+0.8% CAGR \uc601\ud5a5): \uac00\uce58 \uae30\ubc18 \uacc4\uc57d\uacfc \uac19\uc740 \ud601\uc2e0\uc801\uc778 \uc0c1\ud658 \ubaa8\ub378\uc740 \uce58\ub8cc \ube44\uc6a9\uacfc \uc784\uc0c1 \uacb0\uacfc \uac04\uc758 \uc5f0\uad00\uc131\uc744 \uac15\ud654\ud558\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc81c\uc57d \uc694\uc778:<\/p>\n<p>*   \ub192\uc740 \uce58\ub8cc \ube44\uc6a9 (\u22121.9% CAGR \uc601\ud5a5): \ubbf8\uad6d\uc5d0\uc11c \ud658\uc790\ub2f9 \uc5f0\uac04 20\ub9cc~30\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\ub294 \ub192\uc740 \uce58\ub8cc \ube44\uc6a9\uc740 \ubcf4\ud5d8\uc0ac\uc758 \uc608\uc0b0\uc744 \uc555\ubc15\ud558\uba70, \uc758\ub8cc \uc9c0\ucd9c\uc774 \uc801\uc740 \uc2e0\ud765 \uacbd\uc81c\uad6d\uc5d0\uc11c\uc758 \uad11\ubc94\uc704\ud55c \ucc44\ud0dd\uc744 \uc5b4\ub835\uac8c \ud569\ub2c8\ub2e4. \uc720\ub7fd\uc758 \uc0c1\ud658\uc728\uc740 \ud3f4\ub780\ub4dc\uc758 27%\uc5d0\uc11c \ub374\ub9c8\ud06c\uc758 88%\uae4c\uc9c0 \ub2e4\uc591\ud558\uc5ec, \ubd88\uade0\ub4f1\ud55c \uc811\uadfc\uc131\uc744 \uc57c\uae30\ud558\uace0 \uc218\uc694\ub97c \ubd84\uc5f4\uc2dc\ud0a4\uba70 \uc218\uc775 \uac00\uc2dc\uc131\uc744 \uc800\ud574\ud569\ub2c8\ub2e4.<br \/>\n*   \uba74\uc5ed\uc6d0\uc131 \ubb38\uc81c (\u22121.3% CAGR \uc601\ud5a5): \ud6a8\uc18c \uce58\ub8cc \ud658\uc790\uc758 \uc808\ubc18\uc740 \uacb0\uad6d \ud56d\uc57d\ubb3c \ud56d\uccb4(anti-drug antibodies)\ub97c \uc0dd\uc131\ud558\uba70, \uc77c\ubd80\ub294 \uce58\ub8cc \ud6a8\ub2a5\uc744 \uc911\ud654\uc2dc\ud0a4\uac70\ub098 \uc8fc\uc785 \ubc18\uc751\uc744 \uc720\ubc1c\ud558\uc5ec \uce58\ub8cc \uc911\ub2e8\uc744 \uac15\uc694\ud569\ub2c8\ub2e4. \uc6a9\ub7c9 \uc99d\ub7c9\uc774\ub098 \uba74\uc5ed \uad00\uc6a9 \uc720\ub3c4\uc640 \uac19\uc740 \ud574\uacb0\ucc45\uc740 \ube44\uc6a9\uc744 \uc99d\uac00\uc2dc\ud0a4\uace0 \uce58\ub8cc\ub97c \ubcf5\uc7a1\ud558\uac8c \ub9cc\ub4ed\ub2c8\ub2e4.<br \/>\n*   \uc2e0\ud765 \uce58\ub8cc\ubc95\uacfc\uc758 \uacbd\uc7c1 (\u22121.1% CAGR \uc601\ud5a5): FLT201\uacfc \uac19\uc740 \uc2e0\ud765 \uc720\uc804\uc790 \uce58\ub8cc\ubc95\uc740 \ubc14\uc774\uc624\ub9c8\ucee4 \ubd80\ub2f4\uc744 \uc904\uc77c \uc218 \uc788\uc5b4 \uc7a5\uae30\uc801\uc73c\ub85c \ud6a8\uc18c \ub300\uccb4 \uc694\ubc95\uc758 \uc218\uc694\ub97c \uc7a0\uc2dd\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uacf5\uae09\ub9dd \ubb38\uc81c (\u22120.9% CAGR \uc601\ud5a5): \uae00\ub85c\ubc8c \ucdcc\uc7a5 \ud6a8\uc18c \ubd80\uc871 \uc0ac\ud0dc\uc640 \uac19\uc740 \uacf5\uae09\ub9dd \ucde8\uc57d\uc131\uc740 \ud658\uc790 \uce58\ub8cc\uc758 \uc5f0\uc18d\uc131\uc744 \ubc29\ud574\ud558\uace0 \uc2dc\uc7a5\uc5d0 \ubd80\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce60 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8\ubcc4 \ubd84\uc11d<\/p>\n<p>*   \ud6a8\uc18c \uc720\ud615\ubcc4: \uc774\ubbf8\uae00\ub8e8\uc138\ub77c\uc81c\ub294 \uace0\uc154\ubcd1 \uad00\ub9ac\uc5d0\uc11c \ud655\uace0\ud55c \uc5ed\ud560\uc744 \ud574\uc654\uc73c\ub098, \uc544\ubc1c\uae00\ub8e8\ucf54\uc2dc\ub2e4\uc81c \uc54c\ud30c\ub294 \ud3fc\ud398\ubcd1 \ud504\ub85c\ud1a0\ucf5c\uc5d0\uc11c \ud5a5\uc0c1\ub41c \ub9ac\uc18c\uc880 \ud45c\uc801\ud654\uc5d0 \ud798\uc785\uc5b4 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ucc28\uc138\ub300 \uc81c\uc81c \uc2dc\uc7a5\uc740 \ub354 \uae34 \ubc18\uac10\uae30, \ub0ae\uc740 \uba74\uc5ed\uc6d0\uc131, \uac10\uc18c\ub41c \uc8fc\uc785 \ube48\ub3c4\ub97c \uc57d\uc18d\ud558\ub294 PEG\ud654 \ub610\ub294 \ub2f9\ud654 \uacf5\ud559\uc801 \uad6c\uc870\ub85c \uc804\ud658\ud568\uc5d0 \ub530\ub77c \ube60\ub974\uac8c \ud655\ub300\ub420 \uac83\uc785\ub2c8\ub2e4.<br \/>\n*   \uc801\uc6a9 \ubd84\uc57c\ubcc4: \uace0\uc154\ubcd1 \uce58\ub8cc \ud504\ub85c\ud1a0\ucf5c\uc740 \uc5ec\ub7ec \uc2b9\uc778\ub41c \uc790\uc0b0\uacfc \uc798 \ud655\ub9bd\ub41c \ud22c\uc5ec \uc54c\uace0\ub9ac\uc998 \ub355\ubd84\uc5d0 ERT \uc2dc\uc7a5 \uaddc\ubaa8\uc758 \uc0c1\ub2f9 \ubd80\ubd84\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4. \ud3fc\ud398\ubcd1\uc740 \uc2dc\ud30c\uae00\ub8e8\ucf54\uc2dc\ub2e4\uc81c \uc54c\ud30c(cipaglucosidase alfa)\uc640 \ubbf8\uae00\ub8e8\uc2a4\ud0c0\ud2b8(miglustat) \ubcd1\uc6a9 \uc694\ubc95\uc774 \ub2e8\ub3c5 \uc694\ubc95\ubcf4\ub2e4 \uc6b0\uc218\ud55c \uc131\uacfc\ub97c \ubcf4\uc774\uba74\uc11c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c\ubcc4: \uc815\ub9e5 \uc8fc\uc785\uc740 \uae30\uc874 \uce58\ub8cc \ubaa8\ub378\uacfc \ubcd1\uc6d0 \uc778\ud504\ub77c\ub85c \uc778\ud574 2025\ub144 \ub9e4\ucd9c\uc758 \ub300\ubd80\ubd84\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615\uc740 \ud658\uc790\uc758 \uc790\uc728\uc131\uacfc \uc9e7\uc740 \uc9c4\ub8cc \uc2dc\uac04\uc744 \uc120\ud638\ud558\ub294 \uacbd\ud5a5\uc5d0 \ud798\uc785\uc5b4 10.12%\uc758 CAGR\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc81c\ud615\ubcc4: \ud45c\uc900 \uc7ac\uc870\ud569 \ud6a8\uc18c\ub294 30\ub144\uac04\uc758 \uc784\uc0c1\uc801 \uce5c\uc219\uc131\uacfc \uac04\uc18c\ud654\ub41c \uaddc\uc81c \uacbd\ub85c\ub97c \ubc18\uc601\ud558\uc5ec 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 54.60%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 PEG\ud654 \uad6c\uc870\ub294 \ubc18\uac10\uae30\ub97c \uc5f0\uc7a5\ud558\uace0 \ud22c\uc5ec \ube48\ub3c4\ub97c \uc904\uc5ec 9.85%\uc758 CAGR\uc744 \uae30\ub85d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ubcd1\uc6d0 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9\uc774 2025\ub144 \ub9e4\ucd9c\uc758 71.90%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uc7ac\ud0dd \uc758\ub8cc \ud658\uacbd\uc740 25-50%\uc758 \uba85\ud655\ud55c \ube44\uc6a9 \uc6b0\uc704\uc640 \uc6b0\uc218\ud55c \ud658\uc790 \ubcf4\uace0 \uacb0\uacfc \ub355\ubd84\uc5d0 12.10%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4 \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 38.10%\uc758 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud588\uc73c\uba70, \uc798 \uac16\ucdb0\uc9c4 \ubcf4\ud5d8 \uc81c\ub3c4\uc640 \ud76c\uadc0 \uc9c8\ud658 \uc2b9\uc778\uc744 \uac00\uc18d\ud654\ud558\ub294 FDA\uc758 \uc9c0\uc6d0\uc744 \uacc4\uc18d \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uacb0\uacfc \uae30\ubc18 \uacc4\uc57d\uc740 \uacac\uc778\ub825\uc744 \uc5bb\uace0 \uc788\uc73c\uba70, \uc81c\uc870\uc5c5\uccb4\ub294 \uc804\ubb38 \uc57d\uad6d \ub124\ud2b8\uc6cc\ud06c\ub97c \ud65c\uc6a9\ud558\uc5ec \ub2f9\uc77c \ubc30\uc1a1\uc744 \uc2e4\ud589\ud558\uace0 \uc21c\uc751\ub3c4\ub97c \ub192\uc785\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \ub374\ub9c8\ud06c\uac00 \ube44\uc6a9\uc758 88%\ub97c \uc0c1\ud658\ud558\ub294 \ubc18\uba74 \ud3f4\ub780\ub4dc\ub294 27%\ub9cc\uc744 \ubcf4\uc7a5\ud558\ub294 \ub4f1 \uc811\uadfc\uc131 \uce21\uba74\uc5d0\uc11c \ud63c\uc7ac\ub41c \uc591\uc0c1\uc744 \ubcf4\uc785\ub2c8\ub2e4. \uc720\ub7fd\uc758\uc57d\ud488\uccad(EMA)\uc744 \ud1b5\ud55c \uc911\uc559 \uc9d1\uc911\uc2dd \uc2b9\uc778\uc740 \uc11c\ub958 \uc81c\ucd9c\uc744 \uac04\uc18c\ud654\ud558\uc9c0\ub9cc, \uc2b9\uc778 \ud6c4 \uac00\uaca9 \ud611\uc0c1\uc740 \uc218\ub144\uc774 \uac78\ub9b4 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 10.08%\uc758 CAGR\ub85c ERT \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \uacf5\uaca9\uc801\uc778 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac, \uac00\uacc4 \uc18c\ub4dd \uc99d\uac00, \ud604\uc9c0 \uc0dd\uc0b0 \ud5c8\ube0c\uc5d0 \ud798\uc785\uc5b4 \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc911\uad6d\uc758 \uc720\uc804\uccb4 \ud328\ub110\uc740 \uc608\uc0c1\ubcf4\ub2e4 \ub192\uc740 \ub9ac\uc18c\uc880 \uc9c8\ud658 \ubc1c\uc0dd\ub960\uc744 \ubc1d\ud600\ub0c8\uace0, \uc774\ub294 1\ub144\ucc28 \uce58\ub8cc\ub97c \ubcf4\uc870\ud558\ub294 \uc9c0\ubc29 \uc815\ubd80 \uc790\uae08 \uc9c0\uc6d0 \ud504\ub85c\uadf8\ub7a8\uc73c\ub85c \uc774\uc5b4\uc84c\uc2b5\ub2c8\ub2e4. \ud55c\uad6d\uacfc \uc2f1\uac00\ud3ec\ub974\uc758 \uc704\ud0c1 \uc81c\uc870\uc5c5\uccb4\ub4e4\uc740 \ud6a8\uc18c \uc0dd\uc0b0 \ub2a5\ub825\uc744 \ud655\ub300\ud558\uace0 \uc788\uc73c\uba70, \uc778\ub3c4\ub294 \ube44\uc6a9 \uacbd\uc7c1\ub825\uc744 \ud65c\uc6a9\ud558\uc5ec \uad6d\ub0b4 \ubc0f \uc218\ucd9c \uc218\uc694\ub97c \ucda9\uc871\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>ERT \uc2dc\uc7a5\uc740 \uc0ac\ub178\ud53c(\uc820\uc790\uc784), \ub2e4\ucf00\ub2e4, \ubc14\uc774\uc624\ub9c8\ub9b0\uc744 \uc911\uc2ec\uc73c\ub85c \uc911\uac04 \uc815\ub3c4\uc758 \ud1b5\ud569\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub4e4\uc740 \uac15\ub825\ud55c \uc784\uc0c1 \uacbd\ud5d8, \ud2b9\ud5c8 \uc790\uc0b0 \ubc0f \uae00\ub85c\ubc8c \uc720\ud1b5\ub9dd\uc744 \ubcf4\uc720\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc14\uc774\uc624\ub9c8\ub9b0\uc740 2025\ub144 1\ubd84\uae30\uc5d0 \ud6a8\uc18c \uc790\uc0b0\uc5d0\uc11c 4\uc5b5 8,400\ub9cc \ub2ec\ub7ec\uc758 \ub9e4\ucd9c\uc744 \ub2ec\uc131\ud558\uba70 15%\uc758 \ub9e4\ucd9c \uc131\uc7a5\uc744 \uae30\ub85d\ud588\uc2b5\ub2c8\ub2e4. \uae30\uc874 \uae30\uc5c5\ub4e4\uc740 PEG\ud654, \uc735\ud569 \ub2e8\ubc31\uc9c8 \uc124\uacc4 \ubc0f \ud30c\uc774\ud504\ub77c\uc778 \ubc00\ub3c4\ub97c \ub192\uc774\ub294 \uc778\uc218\ub97c \ud1b5\ud574 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \uc9c0\uc18d\uc801\uc73c\ub85c \uac31\uc2e0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2e0\uaddc \uc9c4\uc785\uc790\ub4e4\uc740 \uc7a0\uc7ac\uc801\uc73c\ub85c \uce58\ub8cc \ud6a8\uacfc\uac00 \uc788\ub294 \ubca1\ud130 \ucabd\uc73c\ub85c \uacbd\uc7c1\uc744 \uc804\ud658\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2a4\ud37c \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Spur Therapeutics)\uc758 FLT201\uacfc \ub9ac\uc820\uc5d1\uc2a4\ubc14\uc774\uc624(REGENXBIO)\uc758 RGX-121\uc740 AAV \ud50c\ub7ab\ud3fc\uc744 \uc0ac\uc6a9\ud558\uc5ec \uc9c0\uc18d\uc801\uc778 \ud6a8\uc18c \ubc1c\ud604\uc744 \uc81c\uacf5\ud568\uc73c\ub85c\uc368 \ub9cc\uc131 \uc8fc\uc785 \uc218\uc694\ub97c \uc7a0\uc2dd\ud560 \uc704\ud611\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uac1c\ubc1c\uc5c5\uccb4\ub4e4\uc740 \ub9cc\ub8cc\ub418\ub294 \ud2b9\ud5c8\ub97c \ub178\ub9ac\uace0 \uc788\uc9c0\ub9cc, \ub192\uc740 \ubd84\uc11d \ubc0f \uba74\uc5ed\uc6d0\uc131 \ubb38\uc81c\uc5d0 \uc9c1\uba74\ud574 \ub2e8\uae30\uc801\uc73c\ub85c \uae30\uc874 \uae30\uc5c5\ub4e4\uc744 \ubcf4\ud638\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc81c\uc870 \uaddc\ubaa8 \ub610\ud55c \uacbd\uc7c1\uc758 \uc7a5\uc785\ub2c8\ub2e4. \uc0bc\uc131\ubc14\uc774\uc624\ub85c\uc9c1\uc2a4\ub294 2025\ub144\uae4c\uc9c0 78\ub9cc 4\ucc9c \ub9ac\ud130\uc758 \uc0dd\uc0b0 \ub2a5\ub825\uc744 \uacc4\ud68d\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \ub354 \ube60\ub978 \ucc98\ub9ac \uc2dc\uac04\uacfc \ub0ae\uc740 \ub2e8\uc704 \ube44\uc6a9\uc744 \uc57d\uc18d\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790:<\/p>\n<p>*   \uc0ac\ub178\ud53c(\uc820\uc790\uc784)<br \/>\n*   \ub2e4\ucf00\ub2e4 \uc81c\uc57d(Takeda Pharmaceutical Co. Ltd)<br \/>\n*   \ubc14\uc774\uc624\ub9c8\ub9b0 \uc81c\uc57d(BioMarin Pharmaceutical Inc.)<br \/>\n*   \uc544\ubbf8\ucfe0\uc2a4 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Amicus Therapeutics)<br \/>\n*   \uc6b8\ud2b8\ub77c\uc81c\ub2c9\uc2a4 \uc81c\uc57d(Ultragenyx Pharmaceutical Inc.)<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 3\uc6d4: \uc6b8\ud2b8\ub77c\uc81c\ub2c9\uc2a4(Ultragenyx)\ub294 2025\ub144 1\ubd84\uae30 \ub9e4\ucd9c 1\uc5b5 3,900\ub9cc \ub2ec\ub7ec\ub97c \ubcf4\uace0\ud588\uc73c\uba70, \uc0b0\ud544\ub9ac\ud3ec \uc99d\ud6c4\uad70(Sanfilippo syndrome) \uc720\uc804\uc790 \uce58\ub8cc\uc81c UX111\uc740 2025\ub144 8\uc6d4 18\uc77c PDUFA \uc870\uce58\uc77c\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 3\uc6d4: \uc0ac\ub178\ud53c(Sanofi)\ub294 \ud608\uc6b0\ubcd1 A \ubc0f B\uc5d0 \ub300\ud55c \ucd5c\ucd08\uc758 \ud56d\ud2b8\ub86c\ube48 \uc800\ud558 \uce58\ub8cc\uc81c\uc778 \ud050\ud53c\ud2c0\ub9ac\uc544(Qfitlia, fitusiran)\uc5d0 \ub300\ud574 FDA \uc2b9\uc778\uc744 \ud68d\ub4dd\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 2\uc6d4: FDA\ub294 \ub1cc\uac74\ud669\uc0c9\uc885(cerebrotendinous xanthomatosis)\uc5d0 \ub300\ud55c \ucd5c\ucd08 \uce58\ub8cc\uc81c\uc778 \ud14d\uc2ac\ub9ac(Ctexli, chenodiol)\ub97c \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 2\uc6d4: \ub9ac\uc820\uc5d1\uc2a4\ubc14\uc774\uc624(REGENXBIO)\uc640 \ub2db\ud3f0\uc2e0\uc57c\ucfe0(Nippon Shinyaku)\ub294 RGX-121 \ubc0f RGX-111 MPS \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \ub3c5\uc810 \ud30c\ud2b8\ub108\uc2ed\uc744 \uccb4\uacb0\ud588\uc73c\uba70, 1\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\uc758 \uc120\ubd88\uae08\uacfc \ucd5c\ub300 7\uc5b5 \ub2ec\ub7ec\uc758 \ub9c8\uc77c\uc2a4\ud1a4\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<br \/>\n*   2025\ub144 1\uc6d4: FDA\ub294 POMBILITI \ud2b9\ud5c8 \uc5f0\uc7a5\uc5d0 \ub300\ud55c \uaddc\uc81c \uac80\ud1a0 \uae30\uac04\uc744 \uacb0\uc815\ud558\uace0 2025\ub144 12\uc6d4\uae4c\uc9c0 \uc758\uacac\uc744 \uc218\ub834\ud560 \uc608\uc815\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \ud6a8\uc18c \ub300\uccb4 \uc694\ubc95(Enzyme Replacement Therapy, ERT) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. ERT \uc2dc\uc7a5\uc740 \uc8fc\ub85c \ub9ac\uc18c\uc880 \ucd95\uc801 \uc9c8\ud658 \ubc0f \ub300\uc0ac \uc7a5\uc560\uc640 \uac19\uc740 \ud2b9\uc815 \uc0dd\uccb4 \ub0b4 \ud6a8\uc18c \uacb0\ud54d\uc744 \ubcf4\ucda9\ud558\uae30 \uc704\ud574 \ud22c\uc5ec\ub418\ub294 \ucc98\ubc29 \ub4f1\uae09\uc758 \uc0dd\ubb3c\ud559\uc801 \ud65c\uc131 \ud6a8\uc18c\uc5d0\uc11c \ubc1c\uc0dd\ud558\ub294 \uae00\ub85c\ubc8c \uc218\uc775\uc73c\ub85c \uc815\uc758\ub429\ub2c8\ub2e4. \ubcf8 \uc5f0\uad6c \ubc94\uc704\uc5d0\ub294 \uc77c\ubc18\uc758\uc57d\ud488 \uc18c\ud654 \ud6a8\uc18c \ud63c\ud569\ubb3c, \ubcf5\ud569 \uc81c\uc81c, \uadf8\ub9ac\uace0 \uc804\uc784\uc0c1 \ub2e8\uacc4\uc5d0 \uc788\ub294 \uc720\uc804\uc790 \ud3b8\uc9d1 \ud6a8\uc18c \ud30c\uc774\ud504\ub77c\uc778\uc740 \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21:<br \/>\nERT \uc2dc\uc7a5\uc740 2026\ub144 174\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 268\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc774\ub294 \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc138\ub97c \ub098\ud0c0\ub0c5\ub2c8\ub2e4. \ud2b9\ud788 \uace0\uc154\ubcd1(Gaucher disease) \uce58\ub8cc \ubd84\uc57c\uac00 42.87%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud655\ub300, \ubcf4\ud5d8 \uc801\uc6a9 \ubc94\uc704 \ud655\uc7a5, \ud604\uc9c0 \uc0dd\uc0b0 \uc5ed\ub7c9 \uc99d\ub300\uc5d0 \ud798\uc785\uc5b4 10.08%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc73c\ub85c \uc8fc\ubaa9\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778:<br \/>\n\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \ud76c\uadc0 \uc9c8\ud658 \uc720\ubcd1\ub960 \uc99d\uac00, \uc815\ubd80 \uc778\uc13c\ud2f0\ube0c \ubc0f \uc790\uae08 \uc9c0\uc6d0 \ud655\ub300, \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud504\ub85c\uadf8\ub7a8 \ud655\uc7a5, \ud658\uc790 \uc911\uc2ec \uce58\ub8cc \ubaa8\ub378\ub85c\uc758 \uc804\ud658, \ud6a8\uc18c \uacf5\ud559 \uae30\uc220 \ubc1c\uc804, \uadf8\ub9ac\uace0 \ud601\uc2e0\uc801\uc778 \uc0c1\ud658 \ubaa8\ub378 \ub3c4\uc785 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\ubc18\uba74, \ub192\uc740 \uce58\ub8cc \ube44\uc6a9, \uba74\uc5ed\uc6d0\uc131(immunogenicity) \uc6b0\ub824, \uc2e0\ud765 \uce58\ub8cc\ubc95\uacfc\uc758 \uacbd\uc7c1, \uacf5\uae09\ub9dd \ubb38\uc81c \ub4f1\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654:<br \/>\n\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5\uc744 \ub2e4\uc591\ud55c \uae30\uc900\uc73c\ub85c \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<br \/>\n*   \ud6a8\uc18c \uc720\ud615\ubcc4: \uc774\ubbf8\uae00\ub8e8\uc138\ub77c\uc81c, \uc544\uac08\uc2dc\ub2e4\uc81c \uc54c\ud30c, \uc544\uac08\uc2dc\ub2e4\uc81c \ubca0\ud0c0, \ubca8\ub77c\uae00\ub8e8\uc138\ub77c\uc81c \uc54c\ud30c, \ud0c8\ub9ac\uae00\ub8e8\uc138\ub77c\uc81c \uc54c\ud30c, \uc54c\uae00\ub8e8\ucf54\uc2dc\ub2e4\uc81c \uc54c\ud30c, \uc544\ubc1c\uae00\ub8e8\ucf54\uc2dc\ub2e4\uc81c \uc54c\ud30c, \uac08\uc124\ud30c\uc81c, \uc774\ub450\uc124\ud30c\uc81c \ubc0f \uae30\ud0c0 \ud6a8\uc18c.<br \/>\n*   \uc801\uc6a9 \ubd84\uc57c\ubcc4: \uace0\uc154\ubcd1(1, 2, 3\ud615), \ud3fc\ud398\ubcd1(\uc601\uc544 \ubc0f \ud6c4\uae30 \ubc1c\ubcd1), \ud30c\ube0c\ub9ac\ubcd1, MPS I (\ud5d0\ub7ec \uc99d\ud6c4\uad70), MPS II (\ud5cc\ud130 \uc99d\ud6c4\uad70), MPS IV (\ubaa8\ub974\ud0a4\uc624 \uc99d\ud6c4\uad70) \ubc0f \uae30\ud0c0 \uc801\uc6a9 \ubd84\uc57c.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c\ubcc4: \uc815\ub9e5 \uc8fc\uc785(Intravenous Infusion) \ubc0f \ud53c\ud558 \uc8fc\uc0ac(Sub-Cutaneous).<br \/>\n*   \uc81c\ud615\ubcc4: \ud45c\uc900 \uc7ac\uc870\ud569 \ud6a8\uc18c(Standard Recombinant Enzyme), PEG\ud654\/\uc735\ud569 \ub2e8\ubc31\uc9c8(PEGylated \/ Fusion Proteins), \uc720\uc804\uc790 \ud65c\uc131\ud654 \ucc28\uc138\ub300 \ud6a8\uc18c(Gene-Activated Next-Generation Enzymes).<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ubcd1\uc6d0 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9, \uc7ac\ud0dd \uc758\ub8cc \ud658\uacbd, \uc8fc\uc785 \uc13c\ud130.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ub4f1), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud55c\uad6d \ub4f1), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubc0f \uc8fc\uc694 \uae30\uc5c5:<br \/>\n\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc740 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Sanofi (Genzyme), Takeda Pharmaceutical Co. Ltd, BioMarin Pharmaceutical Inc., Amicus Therapeutics, Ultragenyx Pharmaceutical Inc., GC Pharma (Green Cross Corp.) \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \uc774 \ud504\ub85c\ud544\uc740 \uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \uc0ac\uc5c5 \ubd80\ubb38, \uc7ac\ubb34, \uc778\ub825, \uc8fc\uc694 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704, \uc2dc\uc7a5 \uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ubd84\uc11d \ub4f1\uc744 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\n\ubbf8\ub798 \uc804\ub9dd \ubc0f \uae30\ud68c \uce21\uba74\uc5d0\uc11c\ub294, \uce58\ub8cc \ube44\uc6a9 \uc0c1\uc2b9\uc5d0 \ub300\uc751\ud558\uae30 \uc704\ud574 \uc9c0\ubd88\uc790\ub4e4\uc774 \uac00\uce58 \uae30\ubc18 \uacc4\uc57d \ubc0f \uc131\uacfc \uae30\ubc18 \ud569\uc758\ub97c \ucc44\ud0dd\ud558\uc5ec \uc0c1\ud658\uc744 \uce21\uc815 \uac00\ub2a5\ud55c \uc784\uc0c1 \uac1c\uc120\uacfc \uc5f0\uacc4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uc7ac\ud0dd \uc8fc\uc785(Home-based infusion)\uc774 \ubcd1\uc6d0 \ud658\uacbd \ub300\ube44 \uc9c1\uc811 \uce58\ub8cc \ube44\uc6a9\uc744 25-50% \uc808\uac10\ud558\uace0 \uc21c\uc751\ub3c4\ub97c \ud5a5\uc0c1\uc2dc\ud0a4\uba70 \ud658\uc790 \uce58\ub8cc \ubaa8\ub378\uc744 \uc7ac\ud3b8\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud5a5\ud6c4 10\ub144\uac04 ERT \uc2dc\uc7a5\uc744 \uac00\uc7a5 \ud06c\uac8c \ubcc0\ud654\uc2dc\ud0ac \ud601\uc2e0\uc73c\ub85c\ub294 FLT201 \ubc0f RGX-121\uacfc \uac19\uc740 \uc720\uc804\uc790 \uce58\ub8cc\ubc95\uc774 \ub2e8\uc77c \ud22c\uc5ec\ub85c \uc9c0\uc18d\uc801\uc778 \uce58\ub8cc \ud6a8\uacfc\ub97c \uc81c\uacf5\ud558\uc5ec \ud3c9\uc0dd \uc8fc\uc785\uc758 \ud544\uc694\uc131\uc744 \uc904\uc77c \uc7a0\uc7ac\ub825\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc5f0\uad6c \ubc29\ubc95\ub860:<br \/>\n\ubcf4\uace0\uc11c\uc758 \uc5f0\uad6c \ubc29\ubc95\ub860\uc740 \uc2e0\ub8b0\uc131\uc744 \ud655\ubcf4\ud558\uae30 \uc704\ud574 \uc5c4\uaca9\ud558\uac8c \uc124\uacc4\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc784\uc0c1 \uc720\uc804\ud559\uc790, \uc8fc\uc785 \uc13c\ud130 \uc57d\uc0ac, \ud76c\uadc0 \uc9c8\ud658 \uc639\ud638\uc790\ub4e4\uacfc\uc758 \uc778\ud130\ubdf0 \ubc0f \uc124\ubb38 \uc870\uc0ac\ub97c \ud3ec\ud568\ud558\ub294 1\ucc28 \uc5f0\uad6c\uc640, \uacf5\uac1c\ub41c \uc720\ubcd1\ub960 \ub4f1\ub85d\ubd80, \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ub300\uc2dc\ubcf4\ub4dc, NIH GARD, EuroDIS, \uc77c\ubcf8 NCNP \ub4f1 \ub2f9\uad6d\uc758 \uc0c1\ud658 \uc77c\uc815\uc744 \ub9e4\ud551\ud558\ub294 2\ucc28 \uc5f0\uad6c\ub97c \uacb0\ud569\ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8 \uc0b0\uc815 \ubc0f \uc608\uce21\uc740 \uc0c1\ud5a5\uc2dd \ubc0f \ud558\ud5a5\uc2dd \uc811\uadfc \ubc29\uc2dd\uc744 \ubaa8\ub450 \uc0ac\uc6a9\ud558\uc5ec \uad6d\uac00 \ub4f1\ub85d \ub370\uc774\ud130, \uce58\ub8cc \ud761\uc218\uc728, \ud658\uc790\ub2f9 \ud3c9\uade0 \uc5f0\uac04 \ube44\uc6a9 \ub4f1\uc744 \uae30\ubc18\uc73c\ub85c \ud569\ub2c8\ub2e4. \ub370\uc774\ud130\ub294 \uc5f0\uac04 \uc5c5\ub370\uc774\ud2b8\ub418\uba70, \uc0c8\ub85c\uc6b4 FDA \uc2b9\uc778\uacfc \uac19\uc740 \uc911\ub300\ud55c \uc0ac\uac74 \ubc1c\uc0dd \uc2dc \uc911\uac04 \uc5c5\ub370\uc774\ud2b8\uac00 \uc774\ub8e8\uc5b4\uc9d1\ub2c8\ub2e4. Mordor Intelligence\ub294 \ud22c\uba85\ud55c \uc720\ubcd1\ub960 \uacc4\uc0b0, \uc2e4\uc2dc\uac04 \uac00\uaca9 \ud655\uc778, \ud604\uc7a5 \uc778\ud130\ubdf0\ub97c \ud1b5\ud574 \uc758\uc0ac \uacb0\uc815\uc790\ub4e4\uc774 \uc608\uc0b0 \ucc45\uc815, \ud22c\uc790 \ubc0f \uc815\ucc45 \uacc4\ud68d\uc5d0 \uc2e0\ub8b0\ud560 \uc218 \uc788\ub294 \uade0\ud615 \uc7a1\ud788\uace0 \ubc18\ubcf5 \uac00\ub2a5\ud55c \uae30\uc900\uc120\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-43436","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/43436"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=43436"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/43436\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=43436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=43436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=43436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}